Higher CAC score strongly linked to mortality, CV events in diabetes patients: Study
France: An increase in coronary artery calcium score (CACS) in asymptomatic diabetes patients is strongly associated with an increased risk of mortality and/or fatal and non-fatal cardiovascular events, says a recent study in the Journal of Diabetes and its Complications. This implies that CACS can help to make a decision to start preventive drug therapy in diabetics.
Diabetes' pharmacological management is based mostly on the assessment of cardiovascular risk. For this purpose, CACS is proposed with a soft (class IIb) recommendation, as its prognostic implication in different subsets requires further evidence. Thus, Mamadou Adama Sow, University of Limoges, Limoges, France, and colleagues carried out a systematic review and meta-analysis to address the high CACS prevalence, its prognostic value, and determinants in diabetes, with a special focus on different sex and ethnic groups.
For this purpose, the researchers conducted a systematic review of the published literature in several databases between 01/2000 and 01/2021. Original studies were included if they presented data on the determinants, prevalence, and prognosis of high CACS in diabetes patients without known cardiovascular disease.
Pooled odds ratios (OR) for CACS determinants and Relative Risk (RR) for CACS prognostic values were calculated on all-cause mortality and/or fatal and non-fatal CV events in different categories using random-effects models. A total of 23 studies consisting of 20,999 patients were included.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.